GAT211

GAT211

Biochem/physiol Actions

GAT211 is a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling. GAT211 was found to amplify the therapeutic effect of endocannabinoids without the negative side effects of psychoactivity or tolerance. GAT211 caused a CB1-dependent suppression of paclitaxel-induced mechanical and cold allodynia with no sign of tolerance over 19 days of administration.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3575563 GAT211 white to beige 100 SIGMA-ALDRICH 2-8°C
£490.29 (exc VAT) per 25MG
-
+
3575564 GAT211 white to beige 100 SIGMA-ALDRICH 2-8°C
£96.80 (exc VAT) per 5MG
-
+